医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

CD138在弥漫大B细胞淋巴瘤免疫分型构建及预后评估中的意义

Significance of CD138 in immunohistochemical profiles and its correlation with prognosis in diffuse large B-cell lymphoma

摘要目的 探讨CD138的表达及不同免疫分型方法与弥漫大B细胞淋巴瘤(DLBCL)患者预后的关系.方法 收集106例DLBCL组织标本,应用免疫组化EnVision法检测CD138、CD10、MUM1及bcl-6的表达.基于免疫标记结果,根据4种不同免疫分型方法对106例患者进行分型,比较各亚型患者的预后,分析不同免疫分型方法对DLBCL患者预后的影响.结果 106例组织标本中,CD20均为弥漫阳性,CD3均为阴性,CD10的阳性率为21.7%,bcl-6的阳性率为26.4%,MUM1的阳性率为56.6%,CD138的阳性率为15.1%.其中CD10和bcl-6阳性者总生存期长于阴性者(P=0.001,P=0.041),而CD138阳性者总生存期短于阴性者(P=0.003).多因素Cox回归分析显示,ECOG评分、Hans分型、Colomo分型分别为DLBCL患者生存期(OS)和无进展生存期(PFS)的独立影响因素,两种免疫分型方法相对于OS的OR值(0.259和0.255)和PFS的OR值(0.248和0.244)接近.结论 Hans分型和Colomo分型均与DLBCL患者的预后有关,且对预后的影响力相近,CD138的表达对DLBCL患者预后的预测意义不大.

更多

abstractsObjective The purpose of this study was to classify the diffuse large B-cell lymphoma (DLBCL) into different prognostic subgroups according to four different detection methods of the expression of CD138,CD10,bcl-6,and MUM1.In particular to investigate the significance of CD138 in immunohistochemical profiles and its correlation with prognosis in DLBCL. Methods Immunohistochemical EnVision method was used to detect the expression of CD138,CD10,bcl-6 and MUM1 in 106 cases of DLBCL and reconstructed into four different subtyping algorithms.Algorithm-1,according to the expression of CD10,bcl-6 and MUM1,the cases were assigned to GCB and non-GCB groups.Algorithm-2,according to the expression of CD138,CD10,bcl-6 and MUM1,the cases were assigned to A,B,C,D groups.Algorithm-3,according to the expression of CD10 and MUM1,the cases were assigned to GCB and non-GCB groups.Algorithm-4,according to the expression of CD138,CD10,bcl-6 and MUM1,the cases were assigned to GCB and non-GCB groups.Following up was included as well.Statistical analysis was performed using the SPSS 13.0 and differences were considered significant at P <0.05. Results CD138,MUM1,CD10 and bcl-6 were positive in 15.1%(16/106),56.6%(60/106),21.7(23/106) and 26.4%(28/106),respectively.The expression of CD10 and bcl-6 was associated with favorable OS(P =0.001 and 0.041,respectively),whereas the expression of CD138 was associated with unfavorable OS(P =0.003).Using multivariate Cox proportional hazards regression analysis,algorithm-1 and-4 were almost at the same level for prognosis of OS(OR = 0.259,0.255) and PFS(OR = 0.248,0.244). Conclusions Both Hans's algorithm and Colombo's algorithm including CD138 detection are associated with the prognosis of DLBCL patients.The two algorithms have similar OR value according to Cox analysis.However,positive expression of CD138 is of minor significance in prediction of the prognosis in DLBCL patients.

More
广告
  • 浏览817
  • 下载306
中华肿瘤杂志

中华肿瘤杂志

2011年33卷2期

115-120页

MEDLINEISTICPKUCSCDCA

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷